Dieter Egli, PhD

2012 NYSCF – Robertson Stem Cell Investigator

The New York Stem Cell Foundation

Dr. Egli is a Senior Research Fellow at The New York Stem Cell Foundation. His research focuses on the generation of therapeutically relevant cells for diabetes. His work has relevance for the use of stem cells to study disease, screen for new drugs, and cell replacement therapy. His research creating patient-specific stem cells using the DNA of patients with type 1 diabetes, first published in Nature in October 2011, was named the #1 Medical Breakthrough of 2011 by TIME magazine, which also named him one of 2011’s People Who Mattered. He completed his postdoctoral studies at Harvard University. He received a NYSCF - Druckenmiller Fellowship in 2008.

You are here: NYSCF Home